Podcast
on demand
09
Nov
2022
09
00
CET
Tumour sites
ILD and HER2 targeted agents

This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the third phase of the project will focus on short contributions on the topic by Task Force experts.

 

 

Speakers
Discussant
Rugo Hope
Winterhof Family Professor of Breast Cancer Director, Breast Oncology and Clinical Trials Education Medical Director, Cancer Infusion Services, San Francisco, USA
Expert
Dieras Veronique
Senior Medical Oncologist at Centre Eugène-Marquis, Rennes, France
Login for the Podcast
This material is part of Educational Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project